ALPS Advisors’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-66,026
| Closed | -$469K | – | 905 |
|
|
2019
Q1 | $469K | Buy |
66,026
+2,860
| +5% | +$20.3K | ﹤0.01% | 540 |
|
|
2018
Q4 | $539K | Buy |
63,166
+15,050
| +31% | +$128K | ﹤0.01% | 457 |
|
|
2018
Q3 | $963K | Buy |
48,116
+8,965
| +23% | +$179K | 0.01% | 418 |
|
|
2018
Q2 | $1.01M | Buy |
39,151
+4,057
| +12% | +$105K | 0.01% | 335 |
|
|
2018
Q1 | $839K | Buy |
35,094
+9,853
| +39% | +$236K | 0.01% | 347 |
|
|
2017
Q4 | $855K | Buy |
25,241
+3,069
| +14% | +$104K | 0.01% | 288 |
|
|
2017
Q3 | $469K | Buy |
22,172
+1,990
| +10% | +$42.1K | ﹤0.01% | 630 |
|
|
2017
Q2 | $353K | Buy |
20,182
+1,272
| +7% | +$22.2K | ﹤0.01% | 703 |
|
|
2017
Q1 | $331K | Sell |
18,910
-2,215
| -10% | -$38.8K | ﹤0.01% | 680 |
|
|
2016
Q4 | $357K | Sell |
21,125
-6,831
| -24% | -$115K | ﹤0.01% | 645 |
|
|
2016
Q3 | $459K | Sell |
27,956
-2,426
| -8% | -$39.8K | ﹤0.01% | 316 |
|
|
2016
Q2 | $460K | Buy |
30,382
+6,296
| +26% | +$95.3K | ﹤0.01% | 315 |
|
|
2016
Q1 | $348K | Sell |
24,086
-182
| -0.7% | -$2.63K | ﹤0.01% | 573 |
|
|
2015
Q4 | $687K | Sell |
24,268
-3,628
| -13% | -$103K | 0.01% | 242 |
|
|
2015
Q3 | $4.67K | Buy |
27,896
+10,211
| +58% | +$1.71K | ﹤0.01% | 526 |
|
|
2015
Q2 | $464K | Buy |
+17,685
| New | +$464K | ﹤0.01% | 581 |
|